APP and Alzheimer disease: AD patients, APP/PS1 mice, and Adipo−/− mice all showed decreased levels of AdipoR1 in brain tissue and impaired learning and memory functions, but treatment with an adiponectin-mimetic novel nonapeptide reversed the above changes [17].